Tango Therapeutics Stock Total Debt

TNGX Stock  USD 3.10  0.16  5.44%   
Tango Therapeutics fundamentals help investors to digest information that contributes to Tango Therapeutics' financial success or failures. It also enables traders to predict the movement of Tango Stock. The fundamental analysis module provides a way to measure Tango Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tango Therapeutics stock.
Total Debt To Capitalization is likely to drop to 0 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Tango Therapeutics Company Total Debt Analysis

Tango Therapeutics' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Total Debt

 = 

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current Tango Therapeutics Total Debt

    
  38.92 M  
Most of Tango Therapeutics' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tango Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Tango Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Tango Therapeutics is extremely important. It helps to project a fair market value of Tango Stock properly, considering its historical fundamentals such as Total Debt. Since Tango Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tango Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tango Therapeutics' interrelated accounts and indicators.
0.980.94-0.65-0.850.961.00.921.00.98-0.84-0.75-0.510.970.940.950.930.58
0.980.97-0.71-0.820.920.970.840.980.96-0.87-0.77-0.510.990.960.980.940.57
0.940.97-0.62-0.880.880.920.770.930.94-0.87-0.85-0.640.990.980.970.930.67
-0.65-0.71-0.620.24-0.48-0.63-0.44-0.7-0.540.860.540.03-0.7-0.51-0.78-0.56-0.02
-0.85-0.82-0.880.24-0.84-0.84-0.81-0.81-0.910.640.820.85-0.83-0.94-0.76-0.79-0.89
0.960.920.88-0.48-0.840.970.940.950.94-0.7-0.61-0.440.90.90.870.960.52
1.00.970.92-0.63-0.840.970.950.990.98-0.83-0.73-0.50.950.930.930.920.57
0.920.840.77-0.44-0.810.940.950.910.91-0.68-0.61-0.470.80.810.770.820.53
1.00.980.93-0.7-0.810.950.990.910.97-0.87-0.75-0.480.970.930.960.920.54
0.980.960.94-0.54-0.910.940.980.910.97-0.78-0.76-0.620.950.980.90.90.71
-0.84-0.87-0.870.860.64-0.7-0.83-0.68-0.87-0.780.870.48-0.89-0.79-0.94-0.76-0.43
-0.75-0.77-0.850.540.82-0.61-0.73-0.61-0.75-0.760.870.84-0.81-0.82-0.81-0.65-0.77
-0.51-0.51-0.640.030.85-0.44-0.5-0.47-0.48-0.620.480.84-0.55-0.7-0.47-0.41-0.96
0.970.990.99-0.7-0.830.90.950.80.970.95-0.89-0.81-0.550.960.990.940.59
0.940.960.98-0.51-0.940.90.930.810.930.98-0.79-0.82-0.70.960.910.910.77
0.950.980.97-0.78-0.760.870.930.770.960.9-0.94-0.81-0.470.990.910.930.49
0.930.940.93-0.56-0.790.960.920.820.920.9-0.76-0.65-0.410.940.910.930.47
0.580.570.67-0.02-0.890.520.570.530.540.71-0.43-0.77-0.960.590.770.490.47
Click cells to compare fundamentals

Tango Total Debt Historical Pattern

Today, most investors in Tango Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tango Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Tango Therapeutics total debt as a starting point in their analysis.
   Tango Therapeutics Total Debt   
       Timeline  
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition

Tango Short Long Term Debt Total

Short Long Term Debt Total

21.41 Million

At this time, Tango Therapeutics' Short and Long Term Debt Total is fairly stable compared to the past year.
Based on the latest financial disclosure, Tango Therapeutics has a Total Debt of 38.92 M. This is 98.59% lower than that of the Biotechnology sector and 88.02% lower than that of the Health Care industry. The total debt for all United States stocks is 99.27% higher than that of the company.

Tango Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tango Therapeutics' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tango Therapeutics could also be used in its relative valuation, which is a method of valuing Tango Therapeutics by comparing valuation metrics of similar companies.
Tango Therapeutics is currently under evaluation in total debt category among its peers.

Tango Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Tango Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Tango Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Tango Therapeutics Institutional Holders

Institutional Holdings refers to the ownership stake in Tango Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Tango Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Tango Therapeutics' value.
Shares
Balyasny Asset Management Llc2024-09-30
2.7 M
State Street Corp2024-09-30
2.3 M
Adage Capital Partners Gp Llc2024-09-30
2.3 M
Deerfield Management Co2024-09-30
1.5 M
Geode Capital Management, Llc2024-09-30
1.4 M
Casdin Capital, Llc2024-09-30
1.2 M
Baker Bros Advisors Lp2024-09-30
750 K
Arrowmark Colorado Holdings, Llc (arrowmark Partners)2024-09-30
708.4 K
Bessemer Group Inc2024-09-30
708.4 K
Trv Gp Iv, Llc2024-09-30
16.9 M
Ecor1 Capital, Llc2024-09-30
13.3 M

Tango Fundamentals

About Tango Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Tango Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tango Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tango Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tango Stock Analysis

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.